HIV-1 Residual Viremia Correlates with Persistent T-Cell Activation in Poor Immunological Responders to Combination Antiretroviral Therapy

BACKGROUND: The clinical significance and cellular sources of residual human immunodeficiency virus type 1 (HIV-1) production despite suppressive combination antiretroviral therapy (cART) remain unclear and the effect of low-level viremia on T-cell homeostasis is still debated. METHODOLOGY/PRINCIPAL...

Descripción completa

Detalles Bibliográficos
Autores principales: Mavigner, Maud, Delobel, Pierre, Cazabat, Michelle, Dubois, Martine, L'Faqihi-Olive, Fatima-Ezzahra, Raymond, Stéphanie, Pasquier, Christophe, Marchou, Bruno, Massip, Patrice, Izopet, Jacques
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765414/
https://www.ncbi.nlm.nih.gov/pubmed/19876401
http://dx.doi.org/10.1371/journal.pone.0007658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765414/
https://www.ncbi.nlm.nih.gov/pubmed/19876401
http://dx.doi.org/10.1371/journal.pone.0007658

Ejemplares similares